Cabbacis Inc

OTC:CABI

Cabbacis, Inc. is a development stage, federally-licensed, tobacco product manufacturer and plant biotechnology company committed to developing and commercializing reduced-nicotine cigarettes and vaporizer pods with hemp. The company is headquartered in Niagara Falls, New York and currently employs 5 full-time employees. The company went IPO on 2024-11-01. The firm is focused on commercializing patented harm-reduction tobacco products for smokers led by its flagship iBlend reduced-nicotine cigarettes and vaporizer pods in development. iBlend contains tobacco combined with non-intoxicating hemp to assist in smoking or vaping less, transitioning to less harmful tobacco products, and/or increasing quit attempts. The company also plans to commercialize reduced-nicotine tobacco cigarettes and little cigars without hemp and vaporizer pods with conventional nicotine tobacco and hemp. The Company’s cigarettes and primary vaporizer pods in development include reduced-nicotine tobacco, which contains about 95 percent less nicotine than that of United States brands, and hemp, which contains less than 0.3 percent tetrahydrocannabinol (THC) and therefore is not intoxicating. The company holds a global patent portfolio of 35 issued patents and various pending patent applications.